2024-10-18T13:17:00-05:00 2023-12-31 481032601 ALLEN GIBBS & HOULIK LC 301 N MAIN SUITE 1700 WICHITA KS 672024868 990 2023-01-01 481223461 THE ARTHRITIS RESEARCH CENTER FOUNDATION INC ARTH 3162632125 727 N WACO 200 WICHITA KS 67203 REBECCA SCHUMACHER EXECUTIVE DIRECTOR 3162632125 2024-10-15 1 1 LEANN E STUEVER P01848488 3162677231 2023 2024-10-15 13:58:12Z NATIONAL DATA BANK FOR RHEUMATIC DIS REBECCA SCHUMACHER 727 N WACO 200 WICHITA KS 67203 1693484 0 X N/A X 1999 KS TO INCREASE THE GENERAL BODY OF MEDICAL KNOWLEDGE REGARDING RHEUMATIC DISEASES (ARTHRITIS-RELATED ILLNESSES) BY PERFORMING RESEARCH USING THE DATA BANK AND PUBLISHING THAT RESEARCH IN PEER-REVIEWED MEDICAL JOURNALS. THE CLINICAL RESEARCH IS DESIGNED TO IMPROVE THE TREATMENT AND OUTCOMES OF THESE CONDITIONS. 5 5 12 0 0 0 666094 1263730 372211 414789 4150 5236 5700 9729 1048155 1693484 0 0 0 0 824113 750013 0 0 0 764264 794543 1588377 1544556 -540222 148928 75548 224374 102 0 75446 224374 X TO INCREASE THE GENERAL BODY OF MEDICAL KNOWLEDGE REGARDING RHEUMATIC DISEASES (ARTHRITIS-RELATED ILLNESSES) BY PERFORMING RESEARCH USING THE DATA BANK AND PUBLISHING THAT RESEARCH IN PEER-REVIEWED MEDICAL JOURNALS. THE CLINICAL RESEARCH IS DESIGNED TO IMPROVE THE TREATMENT AND OUTCOMES OF THESE CONDITIONS. 0 0 48373 50000 BRISTOL MYERS SQUIBB: TO EXAMINE WHETHER INCREASES IN GC DOSAGE IN RESPONSE TO INCREASE IN DISEASE ACTIVITY RESULT IN WORSE OUTCOMES COMPARED TO CHANGES/ADDITIONS OF OTHER IMMUNOSUPPRESSIVE MEDICATIONS IN SLE PATIENTS AND HEALTH CARE UTILIZATION ASSOCIATED WITH LEVELS OF GC USE. 42538 15000 MEMS-PFIZER: TO ASSESS MTX AND ADVANCED THERAPY TREATMENT ADHERENCE AND CHARACTERIZE ADHERENCE PATTERNS USING ELECTRONIC MEDICATION MONITORING WITH MEDICATION EVENT MONITORING SYSTEM (MEMS) IN A COHORT OF RA PATIENTS BEING "NEWLY TREATED" (<1 YEAR SINCE INITIATION) WITH PO MTX, MONOTHERAPY OR IN COMBINATION WITH OTHER AGENTS, AND TOFACITANIB, ADALIMUMAB, GOLIMUMAB, AND ETANERCEPT (<6 MONTHS SINCE INITIATION)IN A REAL-WORLD SETTING. 30077 0 UFCW: TO UNDERSTAND HOW UFCW MEMBERS IN THE US HAVE BEEN AFFECTED BY THE COVID-19 PANDEMIC, INCLUDING COVID-RELATED TOPICS SUCH AS TESTING, ILLNESS OUTBREAKS, AND VACCINATION. 1305112 359518 ALL OTHER PROGRAM SERVICE INITIATIVES, INCLUDING REGISTRY THAT USES THE INTERNET TO CREATE A COMMUNITY OF ARTHRITIS PATIENTS, WHO WILLINGLY PROVIDE PATIENT INFORMATION TO BE USED FOR DISCOVERY RESEARCH AND THE DEVELOPMENT OF PERSONALIZED MEDICINE FOR PEOPLE WITH ARTHRITIS, TO GATHER DATA TO BE USED FOR ANALYSES OF HEART DISEASE IN RHEUMATOID ARTHRITIS AND USING THE NDB RA PATIENT DATE FROM 1998 THROUGH JUNE 2011 TO DETERMINE THE MOST COMMON TREATMENT PATHWAYS OVER THE PAST DECADE AND CHARACTERIZE THE PATIENTS ON THESE PATHWAYS. 1305112 359518 1426100 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 12 1 0 0 0 0 0 0 0 0 0 0 0 0 X 5 5 0 0 0 0 1 0 0 1 1 0 0 1 0 0 1 1 1 0 KS X X REBECCA SCHUMACHER 3162632125 727 N WACO STE 200 WICHITA KS 67203 DONNA HAWLEY PHD DIRECTOR 1.00 X 0 0 0 THEODORE PINCUS MD DIRECTOR 1.00 X 0 0 0 JAMES R O'DELL MD DIRECTOR 1.00 X 0 0 0 HYON CHOI MD DIRECTOR 1.00 X 0 0 0 KALEB MICHAUD DIRECTOR 1.00 X 0 0 0 REBECCA SCHUMACHER SECRETARY/TREASURER 40.00 X 87784 0 0 87784 0 0 0 0 0 0 0 1224028 39702 1263730 DATA BANK FOR ARTHRITI 900099 414789 414789 414789 5236 5236 CONSULTING FEE 900099 6400 6400 OTHER INCOME 900099 3329 3329 9729 1693484 424518 0 5236 87784 81066 6718 565504 487295 78209 96725 84151 12574 26015 22216 3799 30493 26529 3964 76762 66783 9979 2575 2575 21489 18695 2794 GRANT RELATED EXPENSES 489901 489901 DATA PROCESSING 143649 143649 EQUIPMENT RENT 3224 2805 419 MEMBERSHIPS & SUBSCRIPT 435 435 1544556 1426100 118456 0 167942 184729 128297 75548 56432 75548 224374 102 0 102 0 X 75446 224374 75446 224374 75548 224374 148928 0 X 0 1 X 0 0 X 826618 1007684 1240090 666094 1263730 5004216 826618 1007684 1240090 666094 1263730 5004216 5004216 48842 4278 38 4150 5236 62544 15402 3810 5777 5700 9729 40418 5107178 1911183 0.97980 0.97120 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 181979 125547 56432 2750 2750 0 56432 1696693 3209 3209 1693484 0 1693484 1547765 3209 3209 1544556 0 1544556 X X X 0 0 0 0 0 0 0 0 0 FORM 990, PART VI, SECTION A, LINE 6 THE ARTHRITIS RESEARCH CENTER FOUNDATION HAS 5 MEMBERS. FORM 990, PART VI, SECTION B, LINE 11B BEFORE FORM 990 IS FILED, IT IS REVIEWED BY REBECCA SCHUMACHER, SECRETARY/EXECUTIVE DIRECTOR. ANY OTHER BOARD COMMITTEE MEMBER MAY REVIEW FORM 990 EITHER BEFORE OR AFTER IT IS FILED. FORM 990, PART VI, SECTION B, LINE 15 PAY FOR HIGHER MANAGEMENT AND DIRECTORS IS DETERMINED BY REVIEW OF RESEARCH ON WHAT THE AVERAGES ARE FOR SIMILAR POSITIONS AND PAY FOR THE DIRECTOR AND EXECUTIVE DIRECTOR ARE APPROVED BY ALL BOARD COMMITTEE MEMBERS. FORM 990, PART VI, SECTION C, LINE 19 THE FORM 990 IS POSTED ON OTHER WEBSITES THAT HAVE A LISTING OF ALL NON-PROFITS. OTHER DOCUMENTS ARE AVAILABLE UPON WRITTEN REQUEST TO THE ORGANIZATION.